David Rescott

Stock Analyst at Truist Securities

(3.21)
# 1,099
Out of 5,036 analysts
70
Total ratings
49.12%
Success rate
2.67%
Average return

Stocks Rated by David Rescott

SI-BONE
Oct 15, 2025
Maintains: Buy
Price Target: $22$20
Current: $15.34
Upside: +30.38%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $123$128
Current: $99.78
Upside: +28.28%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94$96
Current: $95.95
Upside: +0.06%
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300$310
Current: $247.57
Upside: +25.22%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78$79
Current: $76.02
Upside: +3.93%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $50.88
Upside: +70.99%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55$61
Current: $54.88
Upside: +11.16%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $83.77
Upside: +31.31%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $463.73
Upside: +23.99%